Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics

Timely, relevant discussions on diastolic heart failure

Scott L. Hummel (Edited by), Matthew C. Konerman (Edited by)

9780323939812, Elsevier Health Sciences

Hardback, published 13 October 2022

240 pages
28 x 19 x 2.1 cm, 0.54 kg

In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.

• Contains 13 relevant, practice-oriented topics including pharmacologic, non-pharmacologic, and device therapy for HFpEF; geriatric domains in patients with HFpEF; pulmonary hypertension in HFpEF; infiltrative, genetic, and other non-standard causes of HFpEF; echocardiography in HFpEF; and more. 

• Provides in-depth clinical reviews on heart failure with preserved ejection fraction, offering actionable insights for clinical practice. 

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction
Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies
Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction
The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction
Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction
Device Therapy for Heart Failure with Preserved Ejection Fraction
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an “Old? Disease

Subject Areas: Cardiovascular medicine [MJD]